This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2014-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2016
Title: Mariel Donzeau: Innovator in Antibody Research
Introduction
Mariel Donzeau is a prominent inventor based in Strasbourg, France. She has made significant contributions to the field of antibody research, particularly in the treatment of osteolytic conditions. With a total of 2 patents, her work is recognized for its potential impact on medical therapies.
Latest Patents
Mariel Donzeau's latest patents include innovative compositions and methods of use for antibodies targeting Dickkopf-1 (DKK1). These patents provide antibodies and fragments that bind to the protein target DKK1, along with methods of use and kits designed for treating target cells associated with osteolytic conditions. This research holds promise for advancing therapeutic options in this area.
Career Highlights
Throughout her career, Mariel has been associated with Novartis AG, a leading global healthcare company. Her work at Novartis has allowed her to collaborate with other experts in the field and contribute to groundbreaking research in antibody therapies.
Collaborations
Mariel has worked alongside notable colleagues such as Janine R. Shulok and Feng Cong. These collaborations have further enriched her research and development efforts in the field of antibody innovation.
Conclusion
Mariel Donzeau's contributions to antibody research exemplify her dedication to advancing medical science. Her innovative patents and collaborations highlight her role as a key figure in the ongoing development of therapies for osteolytic conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile